Submission Overview

The portal for late breaking submissions is now open. CLICK HERE TO SUBMIT.

Please see the late breaking abstracts tab, for further information, dates and deadlines.

Call for abstracts open24th November 2023
Abstract Submission Deadline
Any abstracts received after this date will not be accepted		29th January 2024
Abstracts notifications sentEarly April 2024
Abstract deadline to withdraw16th April 2024
Deadline to request modifications23rd April 2024
Early bird deadline (abstract presenters only)25th April 2024
Deadline to submit PDF posters for app3rd June 2024

Abstract submission conditions

Please read the instructions below before starting to submit your abstract(s) for consideration.

  1. The abstracts must be submitted through the online submission portal and must only be submitted once.
  2. The person who submits the abstract will be the main contact for it. That person must create an account to upload, edit and save the abstract(s) in the portal. Please keep the email and password used to create the account for future use. Please do not create a new account each time you enter the portal.
  3. Submitted work should be original and not published or accepted for publication in a peer-reviewed journal at the time of abstract submission.
  4. Abstracts will be published in Gut. Authors of all abstracts are required to grant an exclusive licence on a worldwide basis to the BMJ and/or co-owners or contracting owning societies (where published by the BMJ on their behalf) in accordance with the BMJ & BSG licence agreement.
  5. No corrections to the abstract text, authors, affiliations or change of presenting author are permitted following submission. Accepted abstract presenters will have an opportunity to request modifications up until 23rd April 2024. After this, abstracts will be published in Gut as submitted. Further amendments after the 23rd April 2024 will not be permitted.
  6. Please be aware when using special characters and figures/tables that these have been saved correctly. Please ensure that all information provided is correct upon submission.
  7. It is the responsibility of the corresponding contact to communicate with the presenting author and co-authors, and the contact must have the permission of the co-authors to present the abstract if accepted.
  8. The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) in the session and the time assigned by the BSG Programme Committee. The presenting author must register by the deadline given above to confirm that they will present at the conference. Any change of presenter must be confirmed by the withdrawal deadline.

IMPORTANT: It is not a requirement to register for the conference prior to submitting an abstract; however, if the abstract is accepted, the presenting author must register by the date confirmed in the acceptance email. Your abstract(s) will be removed from the programme and abstract book if you have not registered by then. If you require any assistance or have a query about online submission, contact bsg.abstracts@tfilodestar.com 

Presentation Format

An abstract can be submitted for presentation at the conference in one of the following categories:

  • Oral or e-poster presentation
  • E-poster presentation

The decision on which format each accepted abstract will take is made by the Programme Committee and is final. The presenting author will be informed of the decision by the notification outcome deadline (see key dates above). Detailed instructions about e-poster production and oral presentation formats will be provided to presenters once abstracts have been accepted.

Abstract Topics

The abstract topic is a general heading under which the abstract will be reviewed and published. Abstracts must be submitted under the conference topic that best describes the subject of the abstract. The BSG Programme Committee reserves the right to decide on the final topic assignment of the abstract submission.

The following subtopics must also be selected:

  • Medical
  • Laboratory Science
  • Nurse
  • Pathology
  • Sustainability 

The laboratory science*, nurse** and pathology subtopics should be selected only if it is important for people with those areas of expertise to be involved in reviewing the abstract. The sustainability subcategory should be selected if the subject relates to this area. If you are not sure what sub-category is best for you, or if you feel more than one subcategory is relevant to you, please contact bsg.abstracts@tfilodestar.com.

  1. Endoscopy
  2. Endoscopy Video
  3. Inflammatory Bowel Disease
  4. Liver
  5. Oesophagus
  6. Gastroduodenal
  7. Pancreas and neuroendocrine
  8. Small Bowel & Nutrition 
  9. Colon & Anorectal
  10. Neurogastroenterology: functional disorders, motility and clinical physiology
  11. Gastroenterology service: development, delivery, IT
  12. Education & Training

*Laboratory science research is conducted to understand what causes a disease, to analyse the mechanisms by which current treatments work, and to develop potential new therapies. It is done in laboratories using molecules and cells, not in people. Meta-analyses are not basic science.
 
**All abstracts submitted under the subtopic of ‘Nurse’ must have a nurse as the lead author and a nurse must be the presenter at the conference. Furthermore, if an abstract with the nurse subtopic is selected for oral presentation, a nurse must be the lead author and speaker. If a nurse author is unable to present the accepted abstract, it will revert to poster status or will have to be withdrawn. This is BSGNA policy. 

Contact us

Please contact bsg.abstracts@tfilodestar.com for any queries.

Detailed Submission Guidelines

Please adhere to the guidelines when preparing abstracts. Abstracts that are not correctly formatted will not be reviewed.

How to submit an abstract

The online abstract submission system is a simple step-by-step process, which starts with creating an account (or logging back into the account you created earlier, to edit an abstract or submit further abstracts). There is an abstract template for download and the online system will prompt the submitter to provide the required information.

Contacts

The person who submits the abstract will be the contact person for the abstract. This contact person must enter the online submission portal and create an account with an email and password. Please keep a record of these details as they will be required when logging into the BSG abstract submission system.
 
The submitter is required to provide contact information for all authors of the abstract and to specify who submitted the abstract and who will present the abstract. The submitter must receive permission from all parties before submitting the abstract.
 
Upon successful submission of the abstract, a confirmation email will be sent to the abstract contact, presenting author and co-authors. If the confirmation email has not been received, please check that the abstract is not left in draft and is fully submitted by logging back into the portal and checking on the Edit/View Abstracts page.
 
Please note that you can save your submission as a draft and return to edit the submission until the close of submission (see key dates above). The abstract cannot be edited after the close of the submission deadline. Draft abstracts will not be reviewed for inclusion in the programme. If you require any assistance regarding the submission of your abstract, contact bsg.abstracts@tfilodestar.com.

Steps

The online abstract submission system is a simple process. The system will ask you to input the following details:

  • The abstract’s title
  • The preferred format (oral or poster) and topic
  • The name, affiliations and contact email addresses† for all authors.
  • Additional Information:
    1. Publication on the app and website
  • All accepted abstracts may appear in the conference app and on the website. This is a condition of acceptance. These abstracts may be subject to editing. 
    1. Agreement of the BMJ GUT Licence agreement
  • Accepted abstracts will be published in Gut (BMJ) special edition. Authors of abstracts are required to grant an exclusive licence on a worldwide basis to the BMJ and/or co-owners or contracting owning societies (where published by the BMJ on their behalf) in accordance with our standard licence. 
    1. Please state on behalf of all co-authors if you agree to the BMJ licence agreement. If requested the submitting author must be able to supply evidence of this to the BMJ upon written request. By indicating ‘No’, your abstract will not be included in this Gut edition.
      1. Copyright
        • Identify all text or other content forming part of your abstract in which you do not own copyright, and in each case obtain the copyright owner permission for the BMJ Group and BSG to reproduce and publish their material in any media, throughout the world, and to exploit all subsidiary rights for the duration of copyright. Without permission your abstract will have to be excluded from the published abstracts file. If you do not have any copyright restrictions, please state N/A. State in detail your text with copyright you do not own:
      2. Declaration regarding publication status
        • Papers must not be published or accepted for publication in a peer reviewed journal prior to submission.
      3. Conflict of interest declaration
        • BSG intends to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the person submitting the abstract is requested to declare any potential conflicts of interest for and on behalf of all authors during abstract submission.
  • Co-author consent
  • If your abstract has co-authors/presenters and you have provided their emails, do you confirm that you have received their permission to share their contact details (name, affiliation and email) with conference organisers, reviewers and session chairs/moderators for the purpose of conducting the review and compiling the programme? If they do not want their information shared with these stakeholders, the abstract will be excluded from the review and programme.

†Please also provide a non-NHS email for the main contact and the presenting author. We ask this to ensure that important conference information is received and not blocked by firewalls.

Abstract Template

Abstracts must be formatted using the BSG Abstract submission template. You must save as a Word file for uploading to the system. Only WORD files (version 2013 or later) will be accepted for upload.

Format

  • Abstract length must not exceed 3,000 characters (including spaces) .This includes the Title, Authors and Affiliations, and figure/table. Please check this before submitting the abstract. Please note that Gut has a strict 3000 character limit, therefore, if an accepted abstract exceeds this, the end of the abstract will be cut off in publication.
  • The title is limited to 20 words and must clearly indicate the content of the abstract.
  • The main text of the abstract must not include authors & affiliations. This is to keep the abstract as anonymous as possible for review.
  • Abstracts will be published in Gut. The journal applies this strict character count to help with layout, but also to help authors keep material back for full publication purposes. Any abstracts over this maximum character count will be truncated by Gut, with no exceptions. Do not include footnotes. Any references must be included within the body of the text and will be included in the character count.
  • Drug and therapeutic agent names should be referred to by their generic names

Structure

Introduction: 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
Methods: sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
Results: objective data answering the scientific question(s).
Conclusions: only conclusions directly supported by the results, along with implications for clinical practice, avoiding speculation and over-generalisation.

Figures and Tables

  • Only one figure or table may be submitted.
  • Text in these is included in the abstract character limit and may therefore reduce the number of characters considerably.
  • Any figure/table provided must be submitted in monochrome.
  • Keep any figure/table submitted as simple as possible for optimal reproduction. Figures will be sized to fit a single column so complex images with lots of detail are discouraged.
  • The figure legend / table title should appear in the abstract text rather than as part of the figure or table.
  • The figure/table should be cited in the abstract as Figure 1 / Table 1 (whichever is relevant)
  • Images and graphics must adhere to the following criteria:
    Width: min 83mm
    File size: min 35 KB / max 1000 KB
    DPI: min 300

Spelling and Grammar

  • Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be published exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done by the BSG, TFI Lodestar or Gut.
  • Abstracts may only be submitted in English.
  • Abbreviations should be defined on first use.
  • Trade names can be mentioned in the title, as well as in the body of the text.
  • If the abstract contains special characters, consider spelling them out or finding a transferable way for them to reproduce, to avoid errors in the published abstract.

Abstract Corrections

  • During the pre-submission period, the abstract can be edited online as many times as needed, up to the submission.
  • After the abstract has been submitted, it will still be possible to make corrections prior to the submission deadline. Click on View/Edit Abstracts to make any edits to abstracts.
  • No corrections to the abstract text, authors, affiliations or change of presenting author are permitted following submission. Accepted abstract presenters will have an opportunity to request modifications up until 23rd April 2024. After this, abstracts will be published in Gut as submitted. Further amendments after the 23rd April 2024 will not be permitted.

Endoscopy Video Submissions

BSG will consider videos of endoscopic procedures as part of the abstract submission process. Those who would like to submit a video must accompany their video with an abstract in the usual format. If accepted, abstracts and accompanying videos will be publicly presented either as oral presentations or as Endoscopy posters. There will be facilities to show the accompanying video for those abstracts selected for posters. Abstracts will be scored along with their accompanying video.

Video format: Patient confidentiality should be maintained throughout the video. All videos should be no more than five minutes in length and be recorded in an easily accessible format (e.g. files ending with the extensions: mpg / mp4 / wmv / avi – queries to bsg.abstracts@tfilodestar.com
Video submission: All videos must be submitted electronically using We Transfer to bsg.abstracts@tfilodestar.com. For further information or help regarding We Transfer, please feel free to contact us. Please label the video file with the submitting author’s family name and the title of its accompanying written abstract.
Submitting accompanying abstract: All videos must be accompanied by an abstract which must be submitted via the abstract submission portal. Please choose “02. ENDOSCOPY VIDEO” as the topic for your submission.
Deadline to submit: The deadline to submit your video (via WeTransfer) and accompanying abstract (via Submission Portal) is the same as the main abstract deadline given above. If both files (video and text) have not been submitted, the submission will be considered incomplete and will not be reviewed. Following this date, no submissions will be reviewed.

Review and Notification

All abstracts will go through a blind peer review carried out by reviewers selected by the BSG Programme Committee.
 
Notification of acceptance or rejection will be sent to the submitter, presenting authors and all co-authors as stated in the key dates above. Information about presenter bursaries will be shared at this time.

Registration of the Abstract Presenter

When notified of acceptance, the Presenting Author is required to accept the offer by registering for the conference (if not already registered) and paying in full by the abstract presenter registration deadline given on the key dates at the top of this document.

Presenters of accepted abstracts are entitled to pay the early bird registration rate up until this deadline. A link to register at this rate will be provided in the acceptance email. If the link is not used, the standard prevailing rate will apply. After this deadline, the prevailing rate will apply to anyone registering.

If a presenter fails to register by the deadline:

  • The abstract will not be published in Gut.
  • The abstract will be removed from the programme and all BSG-related publications.

Presentation, Modifications & Withdrawals

The presenting author of an accepted abstract must attend and register for the conference. All accepted abstracts will be published in a supplement of Gut, in the BSG conference app and on the online programme.

Changes to Title & Text

The abstract title and text must be correct at the submission deadline. Any changes in the abstract title or body will not be possible after the submission deadline. Abstracts in draft format will not be reviewed. Accepted abstract presenters will have an opportunity to request modifications up until 23rd April 2024. Further amendments after the 23rd April 2024 will not be permitted.

Withdrawals & Changes to Authors

Requests for withdrawal of an accepted abstract must be sent in writing to bsg.abstracts@tfilodestar.com by the withdrawal deadline (see key dates) to avoid publication in the Gut Journal supplement and final programme.

Addition or removal of author names will be permitted until the withdrawal deadline. Changes must be agreed in writing by all authors on the abstract. 

Changes to the presenting author will be permitted until the withdrawal deadline.  

Any withdrawal or change of presenters requested after that date will not be considered and the abstract will be published in Gut. 

Changes to the Published Abstract

It is the responsibility of the abstract submitter to check that the abstract as published in Gut supplement shortly after the conference is correct. If there is an error, this must be raised no later than 4 weeks after the conference, no changes can be made after this time. 

FAQs

We can accept abstracts that have been presented at an International meeting but not another National meeting. Likewise, abstracts presented at the BSG can be presented at International meetings but not National ones. We also recommend changing the title of the abstract and some of the text, so it is not exactly the same.

BSG will accept abstracts on trials that are ongoing, as long as the abstract includes appropriate interim results with related conclusions i.e. not stating “…results will follow.”

Only authors will be included in the publication.

Presenting authors must attend the conference in person. The presenting author must register by the deadline given. Abstracts will be removed from the programme and from publication if the presenting author has not registered by then.

Abstract authors would always be preferred as presenters over non-author presenters. In cases where an author is not available to present, a non-author may cover the presentation. However, the non-author presenter must be familiar with the research design and findings and have a good knowledge of the subject area in order to respond to questions about the presentation even if, unlike the authors, they cannot take direct responsibility for the research. If applicable, an appropriately qualified individual from the sponsoring company (e.g. Medical Director) could present study findings if authors are not available; however, individuals with a commercial role in the sponsoring company (i.e. sales or marketing) should not act as non-author presenters.

If a HCP is unable to be listed as the lead author for an industry submitted abstract, it is recommended that an appropriately qualified individual from the company (e.g., Medical Director, MSL, Researcher) is listed as the lead author. The author(s) listed on abstracts should reflect the people who conducted the research or contributed substantially to the design of the study or to the interpretation of the results, and who were involved in the development of the presentation and are willing to take responsibility for the findings. Individuals with a commercial role in the sponsoring company (i.e., sales or marketing) should not act as authors or presenters.

New for 2024, BSG is accepting late-breaking abstracts for consideration for oral presentation at BSG LIVE’24. Late-breaking abstract submission is strictly for abstracts advancing the field and containing late-breaking and novel data which was not available before the general abstract submission deadline of 29th January 2024. Abstracts will be scored on the quality and significance of the submitted evidence. BSG welcomes submissions describing new therapies and unapproved medications, large phase II or III clinical trial results, and novel basic science discoveries that have not been published or presented at other meetings. This late breaking submission period is not an extension to the general submission period. Case reports, literature reviews, retrospective studies, and abstracts featuring results or data available on the general submission deadline are ineligible. Revisions to previously submitted abstracts and abstracts that have been or will be published (including manuscripts) or presented in any other scientific venue prior to BSG LIVE’24 are also ineligible and will not be reviewed. All formatting and submission rules apply to late-breaking submissions.

Late breaking submissions open 22nd April 2024 and close 3rd May 2024.

The portal for late breaking submissions is now open. CLICK HERE TO SUBMIT.

About:
New for 2024, BSG is accepting late-breaking abstracts for consideration for oral presentation only at BSG LIVE’24. Late-breaking abstract submission is strictly for abstracts advancing the field and containing late-breaking and novel data which was not available or could not have been submitted before the general abstract submission deadline of 29th January 2024. Abstracts will be scored on the quality and significance of the submitted evidence. BSG welcomes submissions describing new therapies and unapproved medications, large phase II or III clinical trial results, and novel basic science discoveries that have not been published or presented at other meetings. This late breaking submission period is not an extension to the general submission period. Case reports, literature reviews, retrospective studies, and abstracts featuring results or data available on the general submission deadline are ineligible. Revisions to previously submitted abstracts and abstracts that have been or will be published (including manuscripts) or presented in any other scientific venue prior to BSG LIVE’24 are also ineligible and will not be reviewed. All formatting and submission rules apply to late-breaking submissions.

Key Dates:

Abstract portal reopens19th April 2024
Abstract portal closes2nd May 2024
Abstracts notifications sentW/c 20th May 2024
Deadline to withdraw24th May 2024